Delayed Endolymphatic Hydrops: Episodic Vertigo of Delayed Onset after Profound Inner Ear Hearing Loss

Similar documents
Intratympanic Gentamicin Therapy for Vertigo in Nonserviceable Ears

Very few dizzy conditions have a surgical treatment SURGICAL MANAGEMENT OF THE DIZZY PATIENT. Surgical Treatments for. Shunts and Sac Surgery

Normal membranous labyrinth. Dilated membranous labyrinth in Meniere's disease (Hydrops)

J.P.S. Bakshi Manual of Ear, Nose and Throat

CITY & HACKNEY PATHFINDER CLINICAL COMMISSIONING GROUP. Vertigo. (1) Vertigo. (4) Provisional Diagnosis. (5) Investigations. lasting days or weeks

Sasan Dabiri, MD, Assistant Professor

Hearing Outcome of Low-tone Compared to High-tone Sudden Sensorineural Hearing Loss

Clinical Characteristics and Short-term Outcomes of Acute Low Frequency Sensorineural Hearing Loss With Vertigo

University of Groningen. Definition Menière Groningen Mateijsen, Dionisius Jozef Maria

Assessing the Deaf & the Dizzy. Phil Bird Senior Lecturer University of Otago, Christchurch Consultant Otolaryngologist CPH & Private

ORIGINAL ARTICLE. Short Tone Burst Evoked Myogenic Potentials

Meniere s disease and Sudden Sensorineural Hearing Loss

Diagnostic criteria for vestibular neuritis

Clinical Significance of Vestibular Evoked Myogenic Potentials in Benign Paroxysmal Positional Vertigo

Management of Ear, Hearing and Balance Disorders: Fact, Fiction, and Future

Vertigo. Definition Important history questions Examination Common vertigo cases and management Summary

A patient with endolymphatic hydrops may experience any combination of the below described symptoms:

Drug delivery to the inner ear

Clinical Characteristics of Labyrinthine Concussion

Intratympanic Injections of a Pharmacologic Agent for the Treatment of Meniere s Disease or Sudden Hearing Loss. Original Policy Date

OTOLOGY. 1. BRIEF DESCRIPTION OF OTOLOGIC TRAINING Rotations that include otologic training are a component of each of the four years of training.

Vestibular-Evoked Myogenic Potentials as a Test of Otolith Function

Long-Term Follow-Up of Tinnitus in Patients with Otosclerosis After Stapes Surgery

Monitoring of Caloric Response and Outcome in Patients With Benign Paroxysmal Positional Vertigo

P0 Antigen Detection in Sudden Hearing Loss and Ménière s Disease: A New Diagnostic Marker?

Intratympanic Gentamicin for Intractable Ménière s Disease A Review and Analysis of Audiovestibular Impact

What is Meniere's disease? What causes Meniere's disease?

INTRATYMPANIC GENTAMICIN PERFUSIONS. ENDOLYMPHATIC HYDROPS (ELH, Meniere s disease)

Gerard J. Gianoli, MD, FACS The Ear and Balance Institute Baton Rouge, Louisiana

Vestibular evoked myogenic potentials: optimal stimulation and clinical application

ORIGINAL CONTRIBUTION

Vestibular Migraine Panel Session. Panelists. Learner Objectives 7/31/2017. Steven Harvey MD. Fallon Schloemer MD.

Page: 1 of 6. Transtympanic Micropressure Applications as a Treatment of Meniere's Disease

T he etiology of sudden deafness can remain

Cochlear Implant, Bone Anchored Hearing Aids, and Auditory Brainstem Implant

Effect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere s Disease

Transtympanic Micropressure Applications as a Treatment of Meniere s Disease

Menièré s Disease. Overview. Clinical Presentation. Pathology. Intratympanic therapy. Mitchell Ramsey, MD Tripler Army Medical Center

Peripheral vestibular disorders will affect 1 of 13 people in their lifetime

G. Doobe, 1 A. Ernst, 1 R. Ramalingam, 2 P. Mittmann, 1 and I. Todt Introduction. 2. Materials and Methods

Vertigo: A practical approach to diagnosis and treatment. John Waterston

What could be reffered to as dizziness by the patient?

ORIGINAL ARTICLE. Assessment of Saccular Function in Children With Sensorineural Hearing Loss

15 Marzo 2014 Aspetti radiologici dei disordini vestibolari: approccio multidisciplinare

Coding with Confidence:

MÉNIÈRE S DISEASE (MD)

ORIGINAL ARTICLE. Study Using Click and Galvanic Vestibular Evoked Myogenic Potentials

Cochlear Implant Impedance Fluctuation in Ménière s Disease: A Case Study

Corporate Medical Policy

Afr. J. Biomed. Res. 13 (May 2010; Research article Acute Phase Reactants in Immune-Related Inner Ear Disease

Hearing loss and fluctuating hearing levels in X-linked hypophosphataemic osteomalacia

Intratympanic therapy of inner ear disease

ﺎﻨﺘﻤﻠﻋ ﺎﻣ ﻻا ﺎﻨﻟ ﻢﻠﻋ ﻻ ﻚﻧﺎﺤﺒﺳ اﻮﻟﺎﻗ ﻢﻴﻜﺤﻟا ﻢﻴﻠﻌﻟا ﺖﻧأ ﻚﻧا ﻢﻴﻈﻌﻟا ﷲا قﺪﺻ HEARING LOSS

Asymmetric vestibular evoked myogenic potentials in unilateral Menière patients

Vertigo. Tunde Magyar MD, PhD

Because dizziness is an imprecise term, a major role of the clinician is to sort patients out into categories

Labyrinthectomy and Vestibular Neurectomy for Intractable Vertiginous Symptoms

Audiology (Clinical Applications)

Ocular Vestibular Evoked Myogenic Potentials to Air Conducted Tone Bursts in Patients with Unilateral Definite Ménière s Disease

MRI Inner Ear Imaging and Tone Burst Electrocochleography in the Diagnosis of

ALESSANDRA RUSSO MD GRUPPO OTOLOGICO

SECONDARY ENDOLYMPHATIC HYDROPS

Auditory Brainstem Evoked Responses In Migraine Patients

Decompression of the Endolymphatic Sac: Vertigo and Hearing Analysis

The Relationship Between Endolymphatic Hydrops in the Vestibule and Low-Frequency Air-Bone Gaps

Progression of Endolymphatic Hydrops in Ménière s Disease as Evaluated by Magnetic Resonance Imaging

DIZZINESS Varieties. : Fainting, hypotension : Rotatory, spinning. : Muscular incoordination : Collapse without LOC: ELH : Disturbed awareness

Vestibular testing: what patients can expect

Transtympanic Micropressure Applications as a Treatment of Meniere s Disease

Labyrinth Anesthesia A Forgotten but Practical Treatment Option in Ménière s Disease

Tenotomy of the middle ear muscles causes a dramatic reduction in vertigo attacks and improves audiological function in definite Meniere s disease

Hearing Function After Intratympanic Application of Gadolinium- Based Contrast Agent: A Long-term Evaluation

Sudden Sensorineural Hearing Loss; Prognostic Factors

Relieve your vertigo symptoms with a simple and effective treatment for Ménière s disease

Study on Hearing Status of Elderly Patients attending a Specialized ENT Hospital (SAHIC)

Acquired Deafness Loss of hearing that occurs or develops sometime in the course of a lifetime, but is not present at birth.

Control of eye movement

Abnormal direction of internal auditory canal and vestibulocochlear nerve

Public Statement: Medical Policy Statement:

Basic Audiogram Interpretation

HISAKUNI FUKUOKA 1, YUTAKA TAKUMI 1, KEITA TSUKADA 1, MAIKO MIYAGAWA 1, TOMOHIRO OGUCHI 1, HITOSHI UEDA 2, MASUMI KADOYA 2 & SHIN-ICHI USAMI 1

Migraine Features in Patients With Meniere s Disease

Benign Paroxysmal Positional Vertigo (BPPV) Structures of importance. The ear is an inertial navigation device. Vestibular Reflexes

ICD10 CODES CODE DESCRIPTION R Abnormal auditory function study H Abnormal auditory perception, bilateral H Abnormal auditory

Management of Idiopathic Sudden Sensorineural Hearing Loss: Experience in Newly Developing Qatar

Morphological Aspects of Inner Ear Disease

Kumagami, Hidetaka; Takahashi, Haru. 6489&volume=129&issue=1&spage=25.

Dizziness: Neurological Aspect

Title. Author(s) Takahashi, Haruo. Issue Date Right.

Intratympanic application of gentamicin for treatment of

Clinical outcomes with betahistine in vestibular disorders

Rawal Medical Journal

Pitfalls in the diagnosis of acoustic neuroma

Abducens nucleus (VI) Baclofen, nystagmus treatment 202, 203,

Otologic (Ear) Dizziness Fistula SCD Bilateral. Other. Neuritis BPPV. Menieres

Indications and contra-indications of auditory brainstem implants. Systematic review and illustrative cases

VERTIGO. Tuesday 20 th February 2018 Dr Rukhsana Hussain. Disclaimers apply:

PERIPHERAL AND CENTRAL AUDITORY ASSESSMENT

Endolymphatic Duct Blockage for Refractory Ménière s Disease: Assessment of Endolymphatic Sac Biopsy on Short-Term Surgical Outcomes

Transcription:

Delayed Endolymphatic Hydrops: Episodic Vertigo of Delayed Onset after Profound Inner Ear Hearing Loss Tamio Kamei 1, MD, PhD and Kenji Watanabe 2, MD 1 Professor emeritus at Gunma University, Japan 2 Chief of Department of Otorhinolaryngology, Kiryu Kosei Hospital, Japan 1. Introduction No matter what the cause, a prolonged case of profound inner ear hearing loss can induce otologic symptoms, similar to those of Meniere's disease, called delayed endolymphatic hydrops (DEH). There are two types of DEH [9]: the ipsilateral, in which vestibular symptoms arise from the profoundly deaf ear, and the contralateral type, in which cochlear and/or vestibular symptom occurs in the better-hearing ear mostly with normal hearing. Typically, ipsilateral DEH involves repetitive severe vertigo accompanied by nausea and vomiting. However, an increase in the degree of hearing loss during episodic vertigo is rarely perceived, because there is already profound hearing loss. On the other hand, contralateral DEH typically induces fluctuating hearing loss, tinnitus and aural fullness in the ear with good hearing and in some cases is also complicated by episodic vertigo. DEH is a relatively new disease concept. This paper provides an explanation of how this concept was established and addresses several related clinical facts that have been identified. 2. The Establishment of the Disease Concept The first clinical cases that became the basis for establishing this disease concept was reported by Kamei et al. [3]. Statistical analyses were conducted of 44 cases of unilateral profound sensorineural hearing loss usually acquired in early childhood due to undetermined etiology, which was called juvenile (-onset) unilateral profound (or total) deafuess. They found that recurrent severe episodic J.-I. Suzuki et al. (eds.), Hearing Impairment Springer-Verlag Tokyo 2004

Delayed Endolymphatic Hydrops 257 vertigo, similar to that of Meniere's disease, developed between the ages of 16 and 60 in nine (20%) of the cases. Subsequently, Nadol et al. [4] and Wolfson and Leiberman [12] simultaneously reported 12 and 5 cases, respectively, of unilateral profound sensorineural hearing loss of various causes, all of which indicated a delayed onset of recurrent episodic vertigo. Among the 17 cases of hearing loss reported, there were five cases (30%) of hearing loss which would fall into the category of 'Juvenile (-onset) unilateral profound deafness. II Other causes of unilateral hearing loss were viral and bacterial labyrinthitis, head trauma and sudden deafness. Both reports stated that labyrinthectomy of the deaf ear produced relief from episodic vertigo. Nadol et al. suggested that episodic vertigo is probably caused by endolymphatic hydrops in the deaf ear. Schuknecht [8] established a hypothesis regarding the pathogenesis of delayed episodic vertigo, stating that such vertigo occurs when the following two conditions are met: I) a labyrinthine insult of sufficient magnitude to cause total deafness but preservation of vestibular function, and 2) delayed atrophy or fibrous obliteration of the endolymphatic resorptive system. This view is widely supported today as a proper explanation of ipsilateral DEH. Furthermore, it has been made clear that patients who have suffered from unilateral profound inner ear hearing loss for a long time also tend to suffer from otologic symptoms in the contralateral ear with normal hearing. Kamei [1] confirmed that of the 27 juvenile unilateral profound deafness patients with a delayed onset of recurrent episodic vertigo, 24 cases (89%) could be attributed to what is called today ipsilateral DEH, while in three of the cases (11 %), otologic symptoms closely resembling those of Meniere's disease were observed in the better-hearing ear that previously had presumably normal hearing. Similar results were obtained by Schuknecht [9] in an analysis of 18 cases of profound inner ear hearing loss of various causes with delayed onset of otologic symptoms. He suggested that the clinical diagnosis for delayed otologic symptoms resembling those of Meniere's disease occurring in patients with profound inner ear hearing loss should be DEH of either the ipsilateral or the contralateral type. As to the pathogenesis of the contralateral type, Schuknecht et al. [10, 11] conducted a series of histopathologic studies of the temporal bone in three cases of contralateral DEH occurring in patients who had been suffering from unilateral hearing loss of unknown etiology since early childhood (which could correspond to juvenile unilateral profound deafness). They deduced that when one ear becomes deaf due to viral infection in early childhood, the contralateral ear is also affected with subclinical viral infection, which eventually causes the ear with normal hearing to develop, over a long period, a histopathology similar to that of Meniere's disease.

258 Kamei and Watanabe 3. Clinical Facts [2] 3.1 The Cause of Hearing Loss preceding DEH The most common cause of the profound hearing loss that precedes DEH is juvenile unilateral profound deafhess, found in more than half of all cases, followed by labyrinthitis induced by otitis media and viral labyrinthitis induced by mumps, measles or influenza. Other causes include acoustic trauma, head trauma, sudden deafhess, bacterial labyrinthitis induced by meningitis, etc., stapedectomy, otosclerosis, bilateral congenital deafhess, cochlear implant and congenital cytomegalovirus infection. 3.2 Latency Period between the Preceding Hearing Loss and the Onset of DEH The latency period between the preceding profound sensorineural hearing loss and the onset of DEH varies from 1 to 74 years. However, in inner ear hearing loss caused by head trauma, especially when the trauma does not involve a temporal bone fracture, DEH may occur even within a month oflatency. 3.3 The Incidence of DEH In their lifetimes, about 30% of juvenile unilateral profound deafhess patients could develop DEH. In general, however, it remains unclear whether the manifestation of DEH is influenced by the cause of the preceding hearing loss. Some reports say that there is no great difference between the incidence of the ipsilateral and the contralateral types. However, most reports indicate that the incidence is much higher for the ipsilateral type. Indirectly estimated, the DEH morbidity rate in the normal population could be as high as 0.05%, which is equivalent to the prevalence rate of Meniere's disease in the normal population. 3.4 The Age of Onset of DEH Fewer cases of DEH occur before the age of 10. It generally occurs sometime between the ages of 11 and 20 or 41 and 60. Cases that occur between the ages of 11 and 20 are mainly of the ipsilateral type caused by juvenile unilateral profound deafhess, while those caused by hearing loss other than juvenile unilateral deafhess usually occur after the age of 20. The age at which DEH first occurs is generally higher for the contralateral type than the ipsilateral type, probably because residual degeneration in the inner ear with good hearing is less severe than that in the ear with profound hearing loss.

Delayed Endolymphatic Hydrops 259 4. Types of DEH and Their Clinical Diagnoses [2,9] 4.1 Ipsilateral DEH Although ipsilateral DEH can occur in patients with bilateral profound inner ear hearing loss, most DEH cases are observed in patients with unilateral profound hearing loss, often with normal hearing in the contralateral ear. So, the guidelines for the clinical diagnosis of typical ipsilateral DEH would be as follows: 1) many years of monaural profound sensorineural hearing loss or anacusis (early phase), 2) development of recurrent vestibular symptoms resembling those of Meniere's disease, mostly rotational vertigo with vegetative symptoms lasting for less than one to several hours (late phase), 3) no perceived fluctuation in hearing loss related to episodic vertigo (when residual hearing is observed in the ear with profound hearing loss, it is possible to prove a fluctuation in hearing loss by repeated audiometry), and 4) exclusion of central nervous system involvement. It is usually difficult to determine the ear causing vertigo when ipsilateral DEH occurs in patients with bilateral profound inner ear hearing loss unless it is accompanied by tinnitus or aural fullness during episodic vertigo. However, a glycerol test using vestibular evoked myogenic potentials (VEMPs) may serve to reveal the presence of endolymphatic hydrops in such cases [5]. 4.2 Contralateral DEH The clinical diagnosis of typical contralateral DEH would be as follows: 1) many years of monaural profound sensorineural hearing loss or anacusis (early phase), 2) development of fluctuating sensorineural hearing loss in the opposite ear which previously had normal hearing (late phase), 3) occurrence of recurrent episodic vertigo similar to that of Meniere's disease (in about 50% of all cases), and 4) exclusion of central nervous system involvement. In many cases of contralateral DEH, only fluctuating hearing loss takes place in the previously normal hearing ear, without the occurrence of vertigo. According to Schuknecht et al. [11], the reason for this, which was based on caloric test results, was that the better-hearing ear in the contralateral cases generally suffers greater pathologic changes in the vestibular labyrinth than the deaf ear of ipsilateral cases. 5. Neurotological Examinations [2] 5.1 Audiometry To make a diagnosis ofdeh, the presence of profound sensorineural hearing loss in one or both ears must be confirmed by pure tone audiometry. When the contralateral type is suspected, repeated audiometry is needed to confirm if a fluctuation in hearing loss is present in the better-hearing ear. Bekesy audiometry is also performed to prove the presence of recruitment in the better-hearing ear.

260 Kamei and Watanabe An increase in the -SP/AP ratio observed by electrocochleography, which suggests the presence of endolymphatic hydrops, is observed in 60% of contralateral DEH cases. 5.2 The Nystagmus Test Spontaneous nystagmus during episodic vertigo in DEH patients is usually horizontal or horizontal rotatory nystagmus, the direction of which is either toward or away from the affected ear, as in Meniere's disease. Vestibular symptoms are usually not present between vertigo attacks, however, head-shaking nystagmus can often be induced by the head-shaking test. 5.3 The Caloric Test If a decreased caloric nystagmus response is proved, the possibility of the same ear being the cause of vertigo is high. However, many cases of profound inner ear hearing loss involve a decreased caloric nystagmus response in general even when there is no DEH. Further, cases of the ipsilateral type sometimes show vestibular paresis in the better-hearing ear. Therefore, this observation cannot be used as a basis for a final determination of the ear responsible for vertigo. 5.4 Vestibular Evoked Myogenic Potential (VEMP) VEMP has become an established test to explore the sacculo-collic reflex [13, 14]. Recent studies [5, 6] show that the glycerol test using VEMPs may be useful to detect endolymphatic hydrops in both cases of the ipsilateral and contralateral DEH. 6. Treatment [2] 6.1 Conservative Treatment DEH requires conservative treatment, such as that typically used in Meniere's disease, including the appropriate concomitant use of diuretics, or steroids for at least 3 to 6 months. This disease often is resistant to conservative treatment, but sometimes episodic vertigo can subside spontaneously. Further, episodic vertigo may disappear within 5 years by conservative treatment in about 65% of patients withdeh,. 6.2 Surgical Treatment When episodic vertigo cannot be controlled by conservative treatment, surgical treatment can be applied for the ipsilateral type. The most effective surgeries are transtympanic or transmastoid labyrinthectomy and translabyrinthine vestibular neurectomy. Transtympanic gentamicin therapy is also effective. Some claim, however, that conservative surgeries, such as endolymphatic sac drainage,

Delayed Endolymphatic Hydrops 261 sacculotomy or cochleosacculotomy, should be considered before a destructive surgery of the labyrinth is selected. For contralateral DEH, labyrinthectomy and trans labyrinthine vestibular neurectomy should not be selected, for they will completely destroy the auditory function of the patient. Even selective vestibular neurectomy by the retrosigmoid or retrolabyrinthine approach could induce or aggravate hearing loss in about 20% of all cases, or in 50% in the long-term follow-up evaluation [7], with the degree of loss ranging from 10dB to profound deafness. Hypacusis of various degrees could occur in any conservative surgery. However, endolymphatic sac drainage is relatively safe in preserving hearing and the possibility of losing all hearing function by endolymphatic sac drainage is less than 2%. Therefore, when surgical treatment is necessary for the contralateral type, endolymphatic sac drainage is recommended. 7. Conclusion DEH is a clinical entity which can be differentiated from Meniere's disease and is typically observed in patients who have been suffering from longstanding (1 to 74 years) unilateral profound inner ear hearing loss. DEH is probably caused by delayed obliteration of the endolymphatic resorptive system of the membranous labyrinth. The most common cause of hearing loss preceding DEH is juvenile ( onset) unilateral profound deafness (early childhood unilateral profound sensorineural hearing loss of unknown etiology), followed by labyrinthitis of various causes as well as physical and acoustic traumas to the inner ear. There are two types ofdeh: the ipsilateral type, in which the ear with profound hearing loss suffers progressive endolymphatic hydrops; and the contralateral type, in which the formation of progressive endolymphatic hydrops takes place in the ear opposite to the previously deafened ear. The incidence of the ipsilateral type is higher than that of the contralateral type. When recurrent episodic vertigo cannot be remedied through conservative treatment, labyrinthectomy and vestibular neurectomy on the deaf ear are curative for ipsilateral DEH. However, there is no such surgical treatment available for the contralateral type. References 1. Kamei T (1978) Delayed vertigo. In Vestibular Mechanisms in Health and Disease (ed) Hood JD. Academic Press, London pp 369-374. 2. Kamei T (2002) Delayed endolymphatic hydrops as a clinical entity. Neurol Psychiatr Brain Res 10: 1-6. 3. Kamei T, Noro H, Yabe T, et al. (1971) Statistical observation of unilateral total deafness and characteristic unilateral total deafness among young children with tendency towards occurrence of dizziness. Otolaryngol (Tokyo) 43: 349-358.

262 Kamei and Watanabe 4. Nadol JB, Weiss AD, Parker SW (1975) Vertigo of delayed onset after sudden deafness. Ann Otol Rhinol Laryngol84: 841-846. 5. Ohki M, Matsuzaki M, Sugasawa K, et al. (2002) Vestibular evoked myogenic potentials in ipsilateral delayed endolymphatic hydrops. ORL J Otorhinolaryngol Relat Spec 64: 424-428. 6. Ohki M, Matsuzaki M, Sugasawa K, et al. (2002) Vestibular evoked myogenic potentials in patients with contralateral delayed endolymphatic hydrops. Eur Arch Otorhinolaryngol 259: 24-26. 7. Pappas DG Jr, Pappas DG Sr (1997) Vestibular nerve section: long-term follow-up. Laryngoscope 107: 1203-1209. 8. Schuknecht HF (1976) Pathophysiology of endolymphatic hydrops. Arch Otorhinolaryngol212: 253-262. 9. Schuknecht HF (1978) Delayed endolymphatic hydrops. Ann Otol Rhinol Laryngol 87: 743-748. 10. Schuknecht HF, Gulya AJ (1983) Endolymphatic hydrops. An overview and classification. Ann Otol Rhinol Laryngol92: Suppl 106: 1-20. 11. Schuknecht HF, Suzuka Y, Zimmermann C (1990) Delayed endolymphatic hydrops and its relationship to Meniere's disease. Ann Otol Rhinol Laryngol 99:843-853. 12. Wolfson RJ, Leiberman A (1975) Unilateral deafness with subsequent vertigo. Laryngoscope 85: 1762-1766. 13. Wu C-H, Young Y-H, Murofushi T (1999) Tone burst-evoked myogenic potentials in human neck flexor and extensor. Acta Otolaryngol 119: 741-744. 14. Young Y-H, Huang T-W, Cheng P-W (2002) Vestibular evoked myogenic potentials in delayed endolymphatic hydrops. Laryngoscope 112: 1623-1626.